N/A
Completed N=87
The Effect of Resistance Training on Proprotein Subtilisin Convertase Kexin 9 Level After Coronary Bypass Surgery
Source: ClinicalTrials.gov NCT02674659 ↗Enrolled (actual)
87
Serious AEs
2.3%
Results posted
Dec 2019
Primary outcomePrimary: PCSK-9 Level — 377.5; 322.53 ng/ml
Summary
This research add resistance training to patients who undergo cardiac rehabilitation program after coronary bypass surgery, comparing the level of PCSK9 level on that group to another group who receives conventional rehabilitation program (only aerobic exercise)
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY PCSK-9 Level |
377.5; 322.53 | — |
| SECONDARY Low Density Lipoprotein |
106.3; 96.2 | — |
| SECONDARY Body Mass Index |
25.3; 24.7 | — |
| SECONDARY High-Density Lipoprotein |
36.1; 37.4 | — |
| SECONDARY Total Cholesterol |
162.2; 162.1 | — |
| SECONDARY Triglyceride |
145.7; 139.4 | — |
| SECONDARY Fasting Blood Glucose |
107.7; 102.4 | — |
| SECONDARY Systolic Blood Pressure |
117.3; 118.8 | — |
| SECONDARY Diastolic Blood Pressure |
73.8; 74.8 | — |
Eligibility Criteria
Inclusion Criteria
- post elective coronary artery bypass surgery
- > 18 years old
- sign informed consent
Exclusion Criteria
- contraindications of resistance training (unstable angina, uncontrolled blood pressure (systolic > 160 mmHg diastolic > 100 mmHg), acute heart failure, pulmonary diseases, arrhythmia malignant)
- musculoskeletal pain, visual analog scale >3
- post congenital heart disease surgery
- post elective coronary artery bypass surgery with malfunction valves (operated or not)
Data sourced from ClinicalTrials.gov (NCT02674659). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.